Iprazochrome: Difference between revisions
Gerald Chi (talk | contribs) (Created page with "__NOTOC__") |
m (Protected "Iprazochrome": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{Drugbox | |||
| Verifiedfields = changed | |||
| Watchedfields = changed | |||
| verifiedrevid = 444424244 | |||
| IUPAC_name = 3-hydroxy-1-isopropylindoline-5,6-dione 5-semicarbazone | |||
| image = Iprazochrome wiki str.png | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|iprazochrome}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| pregnancy_category = | |||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> | |||
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> | |||
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> | |||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | |||
| legal_status = | |||
| routes_of_administration = | |||
<!--Pharmacokinetic data--> | |||
| bioavailability = | |||
| protein_bound = | |||
| metabolism = | |||
| elimination_half-life = | |||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 7248-21-7 | |||
| ATC_prefix = N02 | |||
| ATC_suffix = CX03 | |||
| PubChem = 6381821 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 903A9K181P | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D07297 | |||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | |||
| ChemSpiderID = 4903581 | |||
<!--Chemical data--> | |||
| chemical_formula = | |||
| C=12 | H=16 | N=4 | O=3 | |||
| molecular_weight = 264.28 g/mol | |||
| smiles = CC(C)N1CC(C2=C/C(=N/NC(=O)N)/C(=O)C=C21)O | |||
| InChI = 1/C12H16N4O3/c1-6(2)16-5-11(18)7-3-8(14-15-12(13)19)10(17)4-9(7)16/h3-4,6,11,18H,5H2,1-2H3,(H3,13,15,19)/b14-8- | |||
| InChIKey = XZKVIDLLLOUTSS-ZSOIEALJBX | |||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} | |||
| StdInChI = 1S/C12H16N4O3/c1-6(2)16-5-11(18)7-3-8(14-15-12(13)19)10(17)4-9(7)16/h3-4,6,11,18H,5H2,1-2H3,(H3,13,15,19)/b14-8- | |||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} | |||
| StdInChIKey = XZKVIDLLLOUTSS-ZSOIEALJSA-N | |||
| synonyms = <small>[(3-hydroxy-1-isopropyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea</small> | |||
}} | |||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | |||
== Overview == | |||
'''Iprazochrome''' is an [[antimigraine]] agent. It is a [[serotonin antagonist]].<ref name="pmid2639158">{{cite journal |author=Hampf G |title=Effect of serotonin antagonists on patients with atypical facial pain |journal=J Craniomandib Disord |volume=3 |issue=4 |pages=211–2 |year=1989 |pmid=2639158 |doi= |url=}}</ref> | |||
==References== | |||
{{Reflist|2}} | |||
{{Antimigraine preparations}} | |||
{{Serotonergics}} | |||
[[Category:drug]] | |||
[[Category:Antimigraine drugs]] | |||
[[Category:Semicarbazones]] | |||
[[Category:Indolines]] | |||
[[Category:Alcohols]] | |||
{{analgesic-stub}} |
Latest revision as of 16:32, 20 August 2015
Clinical data | |
---|---|
Synonyms | [(3-hydroxy-1-isopropyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C12H16N4O3 |
Molar mass | 264.28 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Iprazochrome |
Articles |
---|
Most recent articles on Iprazochrome Most cited articles on Iprazochrome |
Media |
Powerpoint slides on Iprazochrome |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Iprazochrome at Clinical Trials.gov Clinical Trials on Iprazochrome at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Iprazochrome
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Iprazochrome Discussion groups on Iprazochrome Patient Handouts on Iprazochrome Directions to Hospitals Treating Iprazochrome Risk calculators and risk factors for Iprazochrome
|
Healthcare Provider Resources |
Causes & Risk Factors for Iprazochrome |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Iprazochrome is an antimigraine agent. It is a serotonin antagonist.[1]
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed ChemSpider identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Drug
- Antimigraine drugs
- Semicarbazones
- Indolines
- Alcohols